Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups
Data Collection
Collected from today forward - ProspectiveBlood-Borne Infections+11
+ Urogenital Diseases
+ Genital Diseases
Summary
Study start date: April 1, 2004
Actual date on which the first participant was enrolled.The rate of HIV infection among adolescents is increasing at an alarming rate. Adherence to antiretroviral therapy has been a major challenge in achieving and maintaining adequate control of the disease in this population. DOT has been shown effective in individuals with tuberculosis (TB), but DOT in HIV infected populations has not been thoroughly examined. This study will collect information from HIV infected adolescents in order to establish a DOT program that will increase successful adherence to HIV treatment and will benefit the public by preventing development of viral resistance and reducing the risk of transmission. Adolescent participants in this study will be assigned to one of three 2-hour focus group sessions, each at a different site. The participants will complete a questionnaire and will give input about designing a DOT intervention model that will be accepted by adolescents. The model will then be used in a pilot study to determine the feasibility of implementing DOT programs in the community to help HIV infected adolescents.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 16 to 21 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * HIV infected due to high-risk behavior * Regular attendee of local adolescent HIV support group * Current use of antiretrovirals or history of antiretroviral therapy * Permission of parent or legal guardian if participant is less than the legal age of consent. Assent of the minor participant should be obtained where required. Exclusion Criteria: * Perinatal HIV infection * Visibly distraught or emotionally unstable * Pregnancy or breast-feeding
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
University of Miami (Pediatric)
Miami, United StatesSt. Jude Childrens Research Hospital, Memphis
Memphis, United States